ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ONVO Organovo Holdings Inc

0.9114
0.0056 (0.62%)
Jun 17 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 103,931
Bid Price 0.9001
Ask Price 0.9299
News -
Day High 0.9279

Low
0.85

52 Week Range

High
2.05

Day Low 0.896
Company Name Stock Ticker Symbol Market Type
Organovo Holdings Inc ONVO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0056 0.62% 0.9114 19:55:02
Open Price Low Price High Price Close Price Prev Close
0.90 0.896 0.9279 0.9114 0.9058
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
588 103,931 $ 0.912564 $ 94,844 - 0.85 - 2.05
Last Trade Time Type Quantity Stock Price Currency
18:34:44 5 $ 0.90 USD

Organovo Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
9.24M 10.04M - 109k -14.67M -1.46 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Organovo News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ONVO Message Board. Create One! See More Posts on ONVO Message Board See More Message Board Posts

Historical ONVO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.971.090.890.9460892178,883-0.0586-6.04%
1 Month1.051.100.890.9876806127,774-0.1386-13.20%
3 Months1.001.740.851.291,131,200-0.0886-8.86%
6 Months1.251.740.851.27602,067-0.3386-27.09%
1 Year1.812.050.851.29349,606-0.8986-49.65%
3 Years8.419.890.851.99160,287-7.50-89.16%
5 Years0.50223.920.19332.19375,1750.409481.55%

Organovo Description

Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo's key instrument platform is the NovoGen Bioprinter. The firm's 3-D bioprinting technologies create tissues using living cells and biocompatible hydrogels.

Your Recent History

Delayed Upgrade Clock